368 related articles for article (PubMed ID: 21609576)
1. [Evaluation of levonorgestrel-releasing intrauterine system in treatment of recurrent endometriosis after conservative surgery].
Xu XW; Zhang YW; He FF; Wang LD; Guan YT; Sun J; Lin M; Hu Y
Zhonghua Fu Chan Ke Za Zhi; 2011 Apr; 46(4):250-4. PubMed ID: 21609576
[TBL] [Abstract][Full Text] [Related]
2. [Levonorgestrel-releasing intrauterine system and combined oral contraceptives as conservative treatments for recurrent ovarian endometriosis: a comparative clinical study].
Xu XW; Wang LD; Zhu XQ; Yan LZ; Guan YT; Zhu SC; Hu Y
Zhonghua Yi Xue Za Zhi; 2011 Apr; 91(15):1047-50. PubMed ID: 21609640
[TBL] [Abstract][Full Text] [Related]
3. [Effects of levonorgestrel-releasing intrauterine system on pain and recurrence associated with endometriosis and adenomyosis].
Deng S; Lang JH; Leng JH; Liu ZF; Sun DW; Zhu L
Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):664-8. PubMed ID: 17199919
[TBL] [Abstract][Full Text] [Related]
4. Randomized clinical trial of a levonorgestrel-releasing intrauterine system and a depot GnRH analogue for the treatment of chronic pelvic pain in women with endometriosis.
Petta CA; Ferriani RA; Abrao MS; Hassan D; Rosa E Silva JC; Podgaec S; Bahamondes L
Hum Reprod; 2005 Jul; 20(7):1993-8. PubMed ID: 15790607
[TBL] [Abstract][Full Text] [Related]
5. The LNG-IUS study on adenomyosis: a 3-year follow-up study on the efficacy and side effects of the use of levonorgestrel intrauterine system for the treatment of dysmenorrhea associated with adenomyosis.
Sheng J; Zhang WY; Zhang JP; Lu D
Contraception; 2009 Mar; 79(3):189-93. PubMed ID: 19185671
[TBL] [Abstract][Full Text] [Related]
6. [Levonorgestrel-releasing intrauterine system for treatment of dysmenorrhea associated with adenomyosis].
Sheng J; Lu D; Zhang JP; Cui GF
Zhonghua Fu Chan Ke Za Zhi; 2006 Jul; 41(7):467-70. PubMed ID: 17083813
[TBL] [Abstract][Full Text] [Related]
7. The levonorgestrel-releasing intrauterine system is associated with a reduction in dysmenorrhoea and dyspareunia, a decrease in CA 125 levels, and an increase in quality of life in women with suspected endometriosis.
Yucel N; Baskent E; Karamustafaoglu Balci B; Goynumer G
Aust N Z J Obstet Gynaecol; 2018 Oct; 58(5):560-563. PubMed ID: 29359457
[TBL] [Abstract][Full Text] [Related]
8. Use of the levonorgestrel-releasing intrauterine system in women with endometriosis, chronic pelvic pain and dysmenorrhea.
Bahamondes L; Petta CA; Fernandes A; Monteiro I
Contraception; 2007 Jun; 75(6 Suppl):S134-9. PubMed ID: 17531605
[TBL] [Abstract][Full Text] [Related]
9. Postoperative medical treatment of chronic pelvic pain related to severe endometriosis: levonorgestrel-releasing intrauterine system versus gonadotropin-releasing hormone analogue.
Bayoglu Tekin Y; Dilbaz B; Altinbas SK; Dilbaz S
Fertil Steril; 2011 Feb; 95(2):492-6. PubMed ID: 20883991
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of the levonorgestrel-releasing intrauterine device in the treatment of recurrent pelvic pain in multitreated endometriosis.
Matorras R; Ballesteros A; Prieto B; Ocerin I; Expósito A; Pijoan JI; Crisol L
J Reprod Med; 2011; 56(11-12):497-503. PubMed ID: 22195333
[TBL] [Abstract][Full Text] [Related]
11. Use of the levonorgestrel intrauterine system in adolescents with endometriosis.
Yoost J; LaJoie AS; Hertweck P; Loveless M
J Pediatr Adolesc Gynecol; 2013 Apr; 26(2):120-4. PubMed ID: 23518190
[TBL] [Abstract][Full Text] [Related]
12. Postoperative levonorgestrel-releasing intrauterine system for pelvic endometriosis-related pain: a randomized controlled trial.
Tanmahasamut P; Rattanachaiyanont M; Angsuwathana S; Techatraisak K; Indhavivadhana S; Leerasiri P
Obstet Gynecol; 2012 Mar; 119(3):519-26. PubMed ID: 22314873
[TBL] [Abstract][Full Text] [Related]
13. Endometriosis-associated pain scores and biomarkers in users of the etonogestrel-releasing subdermal implant or the 52-mg levonorgestrel-releasing intrauterine system for up to 24 months.
Margatho D; Carvalho NM; Bahamondes L
Eur J Contracept Reprod Health Care; 2020 Apr; 25(2):133-140. PubMed ID: 32069126
[No Abstract] [Full Text] [Related]
14. [Clinical study of levonorgestrel-releasing intrauterine system for adenomyosis].
He SM; Zhang YD
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Dec; 26(12):1794-6. PubMed ID: 17259122
[TBL] [Abstract][Full Text] [Related]
15. Effects of the levonorgestrel-releasing intrauterine system on cardiovascular risk markers in patients with endometriosis: a comparative study with the GnRH analogue.
Ferreira RA; Vieira CS; Rosa-E-Silva JC; Rosa-e-Silva AC; Nogueira AA; Ferriani RA
Contraception; 2010 Feb; 81(2):117-22. PubMed ID: 20103448
[TBL] [Abstract][Full Text] [Related]
16. The efficacy, side-effects and continuation rates in women with symptomatic endometriosis undergoing treatment with an intra-uterine administered progestogen (levonorgestrel): a 3 year follow-up.
Lockhat FB; Emembolu JO; Konje JC
Hum Reprod; 2005 Mar; 20(3):789-93. PubMed ID: 15608040
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the levonorgestrel-releasing intrauterine system in women with endometriosis.
Lan S; Ling L; Jianhong Z; Xijing J; Lihui W
J Int Med Res; 2013 Jun; 41(3):548-58. PubMed ID: 23660087
[TBL] [Abstract][Full Text] [Related]
18. Postoperative administration of dienogest plus estradiol valerate versus levonorgestrel-releasing intrauterine device for prevention of pain relapse and disease recurrence in endometriosis patients.
Morelli M; Sacchinelli A; Venturella R; Mocciaro R; Zullo F
J Obstet Gynaecol Res; 2013 May; 39(5):985-90. PubMed ID: 23551827
[TBL] [Abstract][Full Text] [Related]
19. Control of endometriosis-associated pain with etonogestrel-releasing contraceptive implant and 52-mg levonorgestrel-releasing intrauterine system: randomized clinical trial.
Carvalho N; Margatho D; Cursino K; Benetti-Pinto CL; Bahamondes L
Fertil Steril; 2018 Nov; 110(6):1129-1136. PubMed ID: 30396557
[TBL] [Abstract][Full Text] [Related]
20. Is there a role for use of levonorgestrel intrauterine system in women with chronic pelvic pain?
Anpalagan A; Condous G
J Minim Invasive Gynecol; 2008; 15(6):663-6. PubMed ID: 18774757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
